Harnessing the Power of AI to Design Novel Antibiotics
Generative artificial intelligence allowed researchers to design new, synthesizable antibiotics against a dangerous and often drug-resistant human pathogen.
Harnessing the Power of AI to Design Novel Antibiotics
Harnessing the Power of AI to Design Novel Antibiotics
Generative artificial intelligence allowed researchers to design new, synthesizable antibiotics against a dangerous and often drug-resistant human pathogen.
Generative artificial intelligence allowed researchers to design new, synthesizable antibiotics against a dangerous and often drug-resistant human pathogen.
The Scientist spoke with Jonathan Kagan about his idea that immune cells respond to “errors” made by unsuccessful pathogens, not the pathogens themselves.
The international group coordinating emergency vaccines recommends administering one dose instead of two to combat the “dire shortage” of cholera vaccines worldwide.
In work that has not yet been peer-reviewed, researchers present evidence that microbes can and do live inside the venom glands of several dangerous species. It remains unclear whether they’re to blame for infections linked to bites.
Alejandra Manjarrez, PhD | Oct 14, 2021 | 7 min read
Recent studies describe how resident microbiota appear to outcompete unwelcome visitors, either with superior weaponry or by guzzling up local resources.
CDC investigators continue to search for the source of the bacteria that caused four infections—two of them lethal—in four different states. The Scientist spoke with melioidosis expert Bart Currie about the disease.
Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.